Armata Pharmaceuticals (ARMP) Other Working Capital Changes (2013 - 2026)
Armata Pharmaceuticals (ARMP) posted Other Working Capital Changes of -$321000.0 for Q1 2026, down 21.13% sequentially from -$265000.0 in Q4 2025, and down 28.4% YoY from -$448324.0 in Q1 2025.
Armata Pharmaceuticals (ARMP) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Other Working Capital Changes for 9 years, with the latest figure at -$321000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 28.4% year-over-year to -$321000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 million (up 63.74% YoY) and the FY2025 annual result came in at -$1.0 million, up 79.28% from the prior year.
- Other Working Capital Changes declined to -$321000.0 in Q1 2026 per ARMP's latest filing, from -$265000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $5.3 million in Q4 2022 and troughed at -$4.9 million in Q4 2023.
- A 5-year average of -$191588.2 and a median of -$539000.0 in 2025 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 1756.25% in 2022, down 775.0% in 2022.
- Over 5 years, Other Working Capital Changes stood at $2.2 million in 2022, then slumped by 270.54% to -$3.7 million in 2023, then surged by 78.59% to -$798000.0 in 2024, then surged by 66.79% to -$265000.0 in 2025, then dropped by 21.13% to -$321000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$321000.0, -$265000.0, and -$257000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.19 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.58 Bn | 77.59 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.34 Bn | 1.37 Bn |
| 4 | Moderna | 56.52 Bn | 51.38 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.67 Bn | 27.36 Bn | 992.69 Mn |
| 7 | Insmed | 27.27 Bn | 26.11 Bn | 358.27 Mn |
| 8 | BioNTech SE | 27.14 Bn | 8.75 Bn | 668.28 Mn |
| 9 | Royalty Pharma | 27.12 Bn | 26.28 Bn | - |
| 10 | Armata Pharmaceuticals | 188.33 Mn | 164.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.01 Mn |
| Jun 30, 2026 | 2.01 Mn |
| Jun 30, 2026 | 2.01 Mn |
| Mar 31, 2026 | -948,000.00 |
| Mar 31, 2026 | -948,000.00 |
| Mar 31, 2026 | -948,000.00 |
| Dec 31, 2025 | -194,000.00 |
| Dec 31, 2025 | -194,000.00 |
| Dec 31, 2025 | -194,000.00 |
| Sep 30, 2025 | -1.02 Mn |
| Sep 30, 2025 | -1.02 Mn |
| Sep 30, 2025 | -1.02 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Mar 31, 2025 | -539,000.00 |
| Mar 31, 2025 | -539,000.00 |
| Mar 31, 2025 | -539,000.00 |
| Dec 31, 2024 | -3.01 Mn |
| Dec 31, 2024 | -3.01 Mn |